Get the latest crypto news, updates, and reports by subscribing to our free newsletter.
Giấy phép số 4978/GP-TTĐT do Sở Thông tin và Truyền thông Hà Nội cấp ngày 14 tháng 10 năm 2019 / Giấy phép SĐ, BS GP ICP số 2107/GP-TTĐT do Sở TTTT Hà Nội cấp ngày 13/7/2022.
© 2026 Index.vn
A securities fraud class action is pending in the United States District Court for the Central District of California (Douglas v. ImmunityBio, Inc., No. 26-cv-03261). Plaintiffs allege that ImmunityBio and certain executives failed to disclose material information during the Class Period, which ran from January 19, 2026 to March 24, 2026.
The lawsuit is tied to an FDA warning letter dated March 13, 2026 concerning ImmunityBio’s promotional materials for Anktiva. Plaintiffs allege the materials misrepresented the product and suggested it could cure or prevent cancer.
On March 24, 2026, ImmunityBio’s stock closed down 21% to $7.42 per share.
The case is Douglas v. ImmunityBio, Inc., No. 26-cv-03261.

Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…